{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:58:31Z","timestamp":1794409111257,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82503628"],"award-info":[{"award-number":["82503628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32130041"],"award-info":[{"award-number":["32130041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372855"],"award-info":[{"award-number":["82372855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Novel Interdisciplinary Research Project from Shanghai Municipal Health Commission","award":["2022JC023"],"award-info":[{"award-number":["2022JC023"]}]},{"name":"Interdisciplinary Program of Shanghai Jiao Tong University","award":["YG2023ZD04"],"award-info":[{"award-number":["YG2023ZD04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00826-9","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:33:20Z","timestamp":1788777200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis"],"prefix":"10.1186","volume":"15","author":[{"given":"Wangyang","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biaolong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keman","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-6033","authenticated-orcid":false,"given":"Hecheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"1","key":"826_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"826_CR2","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med. 2022;386(21):1973\u201385.","journal-title":"N Engl J Med"},{"issue":"7","key":"826_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41573-022-00493-5","volume":"21","author":"TK Kim","year":"2022","unstructured":"Kim TK, Vandsemb EN, Herbst RS, Chen L. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities. Nat Rev Drug Discov. 2022;21(7):529\u201340.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"826_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-025-01734-x","volume":"18","author":"L Huang","year":"2025","unstructured":"Huang L, Zhu H, Shi Y. Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000\u20132025). J Hematol Oncol. 2025;18(1):107.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"826_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s43018-021-00259-9","volume":"2","author":"J Lehti\u00f6","year":"2021","unstructured":"Lehti\u00f6 J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, et al. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms. Nat Cancer. 2021;2(11):1224\u201342.","journal-title":"Nat Cancer"},{"issue":"1","key":"826_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S, et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Exp Hematol Oncol. 2024;13(1):72.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"826_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol. 2022;19(4):237\u201353.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"826_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54(5):859\u201374.","journal-title":"Immunity"},{"issue":"1","key":"826_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40164-025-00648-1","volume":"14","author":"YP Ding","year":"2025","unstructured":"Ding YP, Liu CC, Yu KD. RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond. Exp Hematol Oncol. 2025;14(1):48.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"826_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L, et al. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022;7(1):334.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"826_CR11","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41580-023-00622-x","volume":"24","author":"H Sun","year":"2023","unstructured":"Sun H, Li K, Liu C, Yi C. Regulation and functions of non-m(6)A mRNA modifications. Nat Rev Mol Cell Biol. 2023;24(10):714\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"826_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Jin H, Li Q, Shi L, Mao Y, Zhao L. The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer. 2024;23(1):130.","journal-title":"Mol Cancer"},{"issue":"10","key":"826_CR13","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, et al. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35(10):1782\u2013e988.","journal-title":"Cell Metab"},{"key":"826_CR14","doi-asserted-by":"crossref","unstructured":"Jiang J, Liu F, Cui D, Xu C, Chi J, Yan T et al. Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2-mediated increase of SOAT2 RNA methylation. Cancer Commun. 2025.","DOI":"10.1002\/cac2.70023"},{"key":"826_CR15","doi-asserted-by":"crossref","unstructured":"Jacoberger-Foissac C, Blake SJ, Liu J, McDonald E, Triscott H, Nakamura K et al. Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy. J Immunother Cancer. 2020;8(2).","DOI":"10.1136\/jitc-2020-001687"},{"issue":"2","key":"826_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1158\/2159-8290.CD-19-0780","volume":"10","author":"F Li","year":"2020","unstructured":"Li F, Huang Q, Luster TA, Hu H, Zhang H, Ng WL, et al. In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma. Cancer Discov. 2020;10(2):270\u201387.","journal-title":"Cancer Discov"},{"issue":"8","key":"826_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11(8):783\u20134.","journal-title":"Nat Methods"},{"issue":"9","key":"826_CR18","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1093\/nar\/gkt178","volume":"41","author":"T Wang","year":"2013","unstructured":"Wang T, Cui Y, Jin J, Guo J, Wang G, Yin X, et al. Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific. Nucleic Acids Res. 2013;41(9):4743\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"826_CR19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","volume":"79","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu L, Liang C, Huang X, Liu Z, Huo J, et al. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. J Hepatol. 2023;79(5):1185\u2013200.","journal-title":"J Hepatol"},{"issue":"1","key":"826_CR20","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"issue":"8","key":"826_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","volume":"72","author":"Y Bao","year":"2023","unstructured":"Bao Y, Zhai J, Chen H, Wong CC, Liang C, Ding Y, et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 2023;72(8):1497\u2013509.","journal-title":"Gut"},{"issue":"7","key":"826_CR22","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.21037\/jtd-21-658","volume":"13","author":"W Meng","year":"2021","unstructured":"Meng W, Liao Y, Chen J, Wang Y, Meng Y, Li K, et al. Upregulation of estrogen receptor beta protein but not mRNA predicts poor prognosis and may be associated with enhanced translation in non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis. 2021;13(7):4281\u2013300.","journal-title":"J Thorac Dis"},{"issue":"1","key":"826_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13578-024-01194-9","volume":"14","author":"W Meng","year":"2024","unstructured":"Meng W, Xiao H, Zhao R, Chen J, Wang Y, Mei P, et al. METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis. Cell Biosci. 2024;14(1):10.","journal-title":"Cell Biosci"},{"issue":"1","key":"826_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","volume":"15","author":"J Hu","year":"2023","unstructured":"Hu J, Zhang L, Xia H, Yan Y, Zhu X, Sun F, et al. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. Genome Med. 2023;15(1):14.","journal-title":"Genome Med"},{"issue":"4","key":"826_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017;171(4):934\u2013e4916.","journal-title":"Cell"},{"issue":"9","key":"826_CR26","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","volume":"52","author":"JW Cho","year":"2020","unstructured":"Cho JW, Hong MH, Ha SJ, Kim YJ, Cho BC, Lee I, et al. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Exp Mol Med. 2020;52(9):1550\u201363.","journal-title":"Exp Mol Med"},{"issue":"1","key":"826_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu JY, Zhang C, Wang X, Zhai L, Ma Y, Mao Y, et al. Integrative Proteomic Characterization of Human Lung Adenocarcinoma. Cell. 2020;182(1):245\u2013e6117.","journal-title":"Cell"},{"issue":"1","key":"826_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K, et al. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020;182(1):200\u2013e2535.","journal-title":"Cell"},{"issue":"8","key":"826_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277\u201389.","journal-title":"Nat Med"},{"issue":"1","key":"826_CR30","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/JS9.0000000000002088","volume":"111","author":"L Wang","year":"2025","unstructured":"Wang L, Chao M, Han RR, Li L, Dong L, Chen F, et al. Single-cell map of diverse immune phenotypes in the metastatic brain tumor microenvironment of nonsmall-cell lung cancer. Int J Surg. 2025;111(1):1601\u20136.","journal-title":"Int J Surg"},{"issue":"1","key":"826_CR31","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.","journal-title":"Nat Commun"},{"issue":"1","key":"826_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41467-023-35832-6","volume":"14","author":"CJ Hanley","year":"2023","unstructured":"Hanley CJ, Waise S, Ellis MJ, Lopez MA, Pun WY, Taylor J, et al. Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer. Nat Commun. 2023;14(1):387.","journal-title":"Nat Commun"},{"issue":"5","key":"826_CR33","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, et al. Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. Immunity. 2019;50(5):1317\u2013e3410.","journal-title":"Immunity"},{"issue":"6","key":"826_CR34","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-12-2321","volume":"19","author":"H Tang","year":"2013","unstructured":"Tang H, Xiao G, Behrens C, Schiller J, Allen J, Chow CW, et al. A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clin Cancer Res. 2013;19(6):1577\u201386.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"826_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2012","unstructured":"Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, et al. Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res. 2012;72(1):100\u201311.","journal-title":"Cancer Res"},{"issue":"11","key":"826_CR36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1200\/JCO.2005.03.8224","volume":"24","author":"T Takeuchi","year":"2006","unstructured":"Takeuchi T, Tomida S, Yatabe Y, Kosaka T, Osada H, Yanagisawa K, et al. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol. 2006;24(11):1679\u201388.","journal-title":"J Clin Oncol"},{"issue":"186","key":"826_CR37","doi-asserted-by":"publisher","first-page":"186ra66","DOI":"10.1126\/scitranslmed.3005723","volume":"5","author":"S Rousseaux","year":"2013","unstructured":"Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med. 2013;5(186):186ra66.","journal-title":"Sci Transl Med"},{"issue":"1","key":"826_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/JTO.0000000000000042","volume":"9","author":"SD Der","year":"2014","unstructured":"Der SD, Sykes J, Pintilie M, Zhu CQ, Strumpf D, Liu N, et al. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. J Thorac Oncol. 2014;9(1):59\u201364.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"826_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12943-025-02394-8","volume":"24","author":"W Ye","year":"2025","unstructured":"Ye W, Zhao Y, Zhou Y, Huang J, He X, Ma Z, et al. NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis. Mol Cancer. 2025;24(1):201.","journal-title":"Mol Cancer"},{"issue":"10","key":"826_CR40","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.molcel.2023.04.028","volume":"83","author":"BW Ng","year":"2023","unstructured":"Ng BW, Xu T, Guo Z. Discovery of chemical probes that perturb protein complexes using size exclusion chromatography and chemical proteomics. Mol Cell. 2023;83(10):1544\u20136.","journal-title":"Mol Cell"},{"issue":"9","key":"826_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559\u201372.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"826_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9(1):176.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"826_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/0008-5472.CAN-23-0902","volume":"84","author":"C Jacobs","year":"2024","unstructured":"Jacobs C, Shah S, Lu WC, Ray H, Wang J, Hockaden N, et al. HSF1 Inhibits Antitumor Immune Activity in Breast Cancer by Suppressing CCL5 to Block CD8\u2009+\u2009T-cell Recruitment. Cancer Res. 2024;84(2):276\u201390.","journal-title":"Cancer Res"},{"key":"826_CR44","doi-asserted-by":"crossref","unstructured":"Tong Y, Chen Z, Wu J, Huang Q, He Y, Shang H et al. METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5\/CCL5 regulation. J Immunother Cancer. 2025;13(4).","DOI":"10.1136\/jitc-2024-011108"},{"issue":"6","key":"826_CR45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","volume":"35","author":"D Dangaj","year":"2019","unstructured":"Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35(6):885\u2013e90010.","journal-title":"Cancer Cell"},{"issue":"4","key":"826_CR46","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrg2005","volume":"8","author":"M Esteller","year":"2007","unstructured":"Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet. 2007;8(4):286\u201398.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"826_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.canlet.2016.01.036","volume":"373","author":"CY Yen","year":"2016","unstructured":"Yen CY, Huang HW, Shu CW, Hou MF, Yuan SS, Wang HR, et al. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers. Cancer Lett. 2016;373(2):185\u201392.","journal-title":"Cancer Lett"},{"issue":"12","key":"826_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877\u2013919.","journal-title":"Protein Cell"},{"issue":"10","key":"826_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","volume":"20","author":"EM Michalak","year":"2019","unstructured":"Michalak EM, Burr ML, Bannister AJ, Dawson MA. The roles of DNA, RNA and histone methylation in ageing and cancer. Nat Rev Mol Cell Biol. 2019;20(10):573\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"826_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2024.11.007","volume":"188","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zeng C, Yang L, Che Y, Chen M, Sau L, et al. YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies. Cell. 2025;188(2):331\u2013e5130.","journal-title":"Cell"},{"issue":"7","key":"826_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.tips.2015.04.013","volume":"36","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Oehme I, Witt O, Oliveira G, Sippl W, Romier C, et al. HDAC8: a multifaceted target for therapeutic interventions. Trends Pharmacol Sci. 2015;36(7):481\u201392.","journal-title":"Trends Pharmacol Sci"},{"key":"826_CR52","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1126\/scitranslmed.aaz6804","volume":"13","author":"W Yang","year":"2021","unstructured":"Yang W, Feng Y, Zhou J, Cheung OK, Cao J, Wang J, et al. A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma. Sci Transl Med. 2021;13:588.","journal-title":"Sci Transl Med"},{"issue":"16","key":"826_CR53","doi-asserted-by":"publisher","first-page":"e2411053","DOI":"10.1002\/advs.202411053","volume":"12","author":"S Liu","year":"2025","unstructured":"Liu S, Ma S, Liu G, Hou L, Guan Y, Liu L, et al. CK2B Induces CD8(+) T-Cell Exhaustion through HDAC8-Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer. Adv Sci (Weinh). 2025;12(16):e2411053.","journal-title":"Adv Sci (Weinh)"},{"key":"826_CR54","doi-asserted-by":"publisher","first-page":"101568","DOI":"10.1016\/j.mtbio.2025.101568","volume":"31","author":"K Liao","year":"2025","unstructured":"Liao K, Gao Y, Cheng M, Zhang Y, Zhao J, Zhou L, et al. Intranasal delivery of AEP inhibitor-loaded neuron-targeted liposome ameliorates radiation-induced brain injury. Mater Today Bio. 2025;31:101568.","journal-title":"Mater Today Bio"},{"key":"826_CR55","doi-asserted-by":"crossref","unstructured":"Guan J, Guo H, Tang T, Wang Y, Wei Y, Seth P et al. iRGD-liposomes enhance tumor delivery and therapeutic efficacy of antisense oligonucleotide drugs against primary prostate cancer and bone metastasis. Adv Funct Mater. 2021;31(24).","DOI":"10.1002\/adfm.202100478"},{"issue":"1","key":"826_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","volume":"18","author":"PL Su","year":"2025","unstructured":"Su PL, Furuya N, Asrar A, Rolfo C, Li Z, Carbone DP, et al. Recent advances in therapeutic strategies for non-small cell lung cancer. J Hematol Oncol. 2025;18(1):35.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"826_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wei J, Feng L, Li O, Huang L, Zhou S, et al. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22(1):81.","journal-title":"Mol Cancer"},{"issue":"4","key":"826_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00262-025-03986-5","volume":"74","author":"Y Yang","year":"2025","unstructured":"Yang Y, Cao L, Xu X, Li D, Deng Y, Li L, et al. NSUN2\/ALYREF axis-driven m(5)C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer. Cancer Immunol Immunother. 2025;74(4):132.","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"826_CR59","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, et al. Defining \u2018T cell exhaustion\u2019. Nat Rev Immunol. 2019;19(11):665\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"826_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"826_CR61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41568-025-00798-8","volume":"25","author":"Z Xiao","year":"2025","unstructured":"Xiao Z, Pur\u00e9 E. The fibroinflammatory response in cancer. Nat Rev Cancer. 2025;25(6):399\u2013425.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"826_CR62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40164-024-00532-4","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang C, Li JJ. Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression. Exp Hematol Oncol. 2024;13(1):64.","journal-title":"Exp Hematol Oncol"},{"issue":"22","key":"826_CR63","doi-asserted-by":"publisher","first-page":"13577","DOI":"10.1093\/nar\/gkae1097","volume":"52","author":"W Miao","year":"2024","unstructured":"Miao W, Porter DF, Li Y, Meservey LM, Yang YY, Ma C, et al. Glucose binds and activates NSUN2 to promote translation and epidermal differentiation. Nucleic Acids Res. 2024;52(22):13577\u201393.","journal-title":"Nucleic Acids Res"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00826-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:33:24Z","timestamp":1788777204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00826-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00826-9","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (2021\u2009\u2212\u2009224). All participants provided written informed consent before their inclusion in the study. All procedures involving animals were conducted in compliance with ethical guidelines and approved by the Institutional Animal Care and Use Committee (IACUC) of the Shanghai Immunology Institute, School of Medicine, Shanghai Jiao Tong University (Approval No. A-2022-031).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"89"}}